iShares Nasdaq Biotechnology (IBB)

Add to Watchlists
Create an Alert
291.04 +2.05  +0.71% NASDAQ Mar 24, 12:00 Delayed 2m USD
View Full Chart
IBB Price Chart

IBB Key Stats

Expense Ratio 0.47%
Share Class Assets Under Management 8.039B
30-Day Average Daily Volume Upgrade
Net Asset Value 288.81
Discount or Premium to NAV 0.06%
Turnover Ratio 24.00

IBB Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -0.11% 0.84% 71
3M 6.12% 10.10% 83
6M -3.02% 0.40% 90
1Y 17.20% 13.78% 52
3Y 4.11% 7.50% 72
5Y 20.30% 16.67% 13
As of March 23, 2017
Returns for periods of 1 year and above are annualized.

IBB Asset Allocation

Type % Net % Long % Short
Cash 0.10% 0.10% 0.00
Stock 99.90% 99.90% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.00 0.00 0.00
As of March 22, 2017

IBB Region Exposure

Americas 98.21%
North America 98.21%
Latin America 0.00
Greater Europe 1.33%
United Kingdom 0.60%
Europe Developed 0.64%
Europe Emerging 0.00
Africa/Middle East 0.10%
Greater Asia 0.46%
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.46%
Market Classification
% Developed Markets 99.54%
% Emerging Markets 0.46%
As of March 21, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

IBB Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 99.90%
Industrials 0.00
Real Estate 0.00
Technology 0.10%
Utilities 0.00
As of March 22, 2017

IBB Stock Market Capitalization

Giant 23.84%
Large 37.25%
Medium 15.14%
Small 13.44%
Micro 10.33%
As of March 22, 2017

IBB Stock Style Exposure

Large Cap Value 3.86%
Large Cap Blend 18.62%
Large Cap Growth 40.50%
Mid Cap Value 0.00
Mid Cap Blend 0.00
Mid Cap Growth 15.13%
Small Cap Value 1.20%
Small Cap Blend 3.33%
Small Cap Growth 17.36%
As of March 22, 2017
View More Holdings

IBB Top 10 Holdings

Symbol Name % Weight Price % Chg
CELG Celgene Corp 8.18% 123.86 +0.52%
BIIB Biogen Inc 7.88% 276.16 +0.27%
GILD Gilead Sciences Inc 7.88% 67.65 +0.24%
AMGN Amgen Inc 7.77% 166.26 +0.13%
REGN Regeneron Pharmaceuticals Inc 6.35% 374.00 +2.46%
INCY Incyte Corp 4.35% 140.06 +0.78%
ILMN Illumina Inc 4.10% 171.24 +2.12%
VRTX Vertex Pharmaceuticals Inc 3.75% 90.42 +1.54%
ALXN Alexion Pharmaceuticals Inc 3.75% 120.48 +0.18%
MYL Mylan NV 3.74% 40.73 -2.10%
As of March 22, 2017
Advertisement

IBB One Page Reports

IBB Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Technology
Fund Owner Firm Name iShares
Benchmark Index
NASDAQ Biotechnology TR USD
100.0%

IBB Manager Info

Name Tenure
Alan Mason 0.87 yrs
Diane Hsiung 9.17 yrs
Greg Savage 9.17 yrs
Jennifer Hsui 4.58 yrs

IBB Net Fund Flows

1M -220.14M
3M -254.88M
6M 574.82M
YTD -240.78M
1Y 1.535B
3Y 2.038B
5Y 3.588B
10Y 3.274B
As of Feb. 28, 2017

IBB Risk Info

Beta (5Y) 1.226
Max Drawdown (All) 62.85%
Historical Sharpe (10Y) 0.779
Historical Sortino (All) 0.5699
30-Day Rolling Volatility 18.03%
Daily Value at Risk (VaR) 1% (All) 4.89%
Monthly Value at Risk (VaR) 1% (All) 19.77%

IBB Fundamentals

Dividend Yield TTM (3-24-17) 0.17%
SEC Yield (12-31-15) 0.00%
Weighted Average PE Ratio 21.20
Weighted Average Price to Sales Ratio 6.124
Weighted Average Price to Book Ratio 4.890
Weighted Median ROE 11.76%
Weighted Median ROA -1.78%
Forecasted Dividend Yield 0.61%
Forecasted PE Ratio 20.32
Forecasted Price to Sales Ratio 4.220
Forecasted Price to Book Ratio 3.920
Number of Holdings 164
As of March 22, 2017

IBB Growth Estimates

Forecasted 5 Yr Earnings Growth 13.99%
Forecasted Book Value Growth 17.14%
Forecasted Cash Flow Growth 16.67%
Forecasted Earnings Growth 13.80%
Forecasted Revenue Growth 15.61%
As of March 22, 2017

IBB Comparables

Edit

IBB Attributes

Key Dates
Inception Date 2/5/2001
Last Annual Report Date 3/31/2016
Last Prospectus Date 8/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

IBB Excel Add-In Codes

  • Name: =YCI("IBB","name")
  • Broad Asset Class: =YCI("IBB", "broad_asset_class")
  • Broad Category: =YCI("IBB", "broad_category_group")
  • Prospectus Objective: =YCI("IBB", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.